PATHSTONE FAMILY OFFICE, LLC - PLURISTEM THERAPEUTICS INC ownership

PLURISTEM THERAPEUTICS INC's ticker is PSTI and the CUSIP is 72940R300. A total of 49 filers reported holding PLURISTEM THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.99 and the average weighting 0.0%.

Quarter-by-quarter ownership
PATHSTONE FAMILY OFFICE, LLC ownership history of PLURISTEM THERAPEUTICS INC
ValueSharesWeighting
Q2 2022$68,036
+13.4%
55,314
+91.1%
0.00%0.0%
Q1 2022$60,000
+42.9%
28,949
-0.4%
0.00%0.0%
Q4 2021$42,000
-41.7%
29,064
+6.3%
0.00%
-50.0%
Q3 2021$72,000
+5.9%
27,347
+58.9%
0.00%0.0%
Q2 2021$68,00017,2100.00%
Other shareholders
PLURISTEM THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
NIA IMPACT ADVISORS, LLC 732,135$1,940,0000.83%
Green Alpha Advisors, LLC 61,759$164,0000.11%
Values First Advisors, Inc. 49,179$130,0000.08%
GSA CAPITAL PARTNERS LLP 257,684$683,0000.07%
SHELTON CAPITAL MANAGEMENT 240,000$636,0000.02%
Walleye Capital LLC 154,997$411,0000.01%
PDT Partners, LLC 59,400$157,0000.01%
Archford Capital Strategies, LLC 13,091$35,0000.01%
Susquehanna International Group Ltd. 13,164$35,0000.01%
MEITAV INVESTMENT HOUSE LTD 167,593$444,0000.01%
View complete list of PLURISTEM THERAPEUTICS INC shareholders